Trials / Completed
CompletedNCT01505426
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
A Phase III, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety of ASP1941 + metformin with metformin alone in Asian subjects with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | oral |
| DRUG | metformin | oral, concomitant use |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2011-11-28
- Primary completion
- 2013-01-14
- Completion
- 2013-01-14
- First posted
- 2012-01-06
- Last updated
- 2024-11-12
Locations
12 sites across 2 countries: South Korea, Taiwan
Source: ClinicalTrials.gov record NCT01505426. Inclusion in this directory is not an endorsement.